Cancer drug victory as thousands benefit

THOUSANDS of lung cancer patients will have access to potentially life-saving immunotherapy cancer drugs, following a ruling by European health chiefs. The announcement, made last week by the European Commission, was prompted by a trial which showed that over two years patients with advanced lung cancer were 51 per cent more likely to survive with immune-boosting drugs than by standard treatment – at least doubling their 12-month life expectancy.
Daily Express :: Health Feed

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *

*